JNJ-40929837 (succinate)
JNJ-40929837 succinate is a selective and orally active LTA4H (leukotriene A4 hydrolase) inhibitor. JNJ-40929837 succinate effectively inhibits aminopeptidase activity and causes serum accumulation of Pro-Gly-Pro. JNJ-40929837 succinate can be used in asthma research[1].
Product Specifications
CAS Number
[1191044-47-9]
UNSPSC
12352005
Target
Aminopeptidase; Leukotriene Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jnj-40929837-succinate.html
Solubility
10 mM in DMSO
Smiles
OC(CCC(O)=O)=O.CC(N[C@@H](C[C@@]1([H])CC2)C[C@@]2([H])N1CC3=CC=C(C=C3)OC4=NC5=NC=CC=C5S4)=O.[x]
Molecular Formula
C22H24N4O2S.xC4H6O4
References & Citations
[1]Low CM, et al. The development of novel LTA4H modulators to selectively target LTB4 generation. Sci Rep. 2017 Mar 17;7:44449.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Explore Other Products
Browse additional items from our catalog
Recombinant Roseiflexus sp. Glutamine amidotransferase subunit pdxT (pdxT)
Recombinant Roseiflexus sp. Glutamine amidotransferase subunit pdxT (pdxT)
Recombinant Roseiflexus sp. Glutamine amidotransferase subunit pdxT (pdxT)